Missouri Patent of the Month – September 2023
Elira, Inc. was founded to combat obesity with neurostimulation technology. Obesity and related health issues have reached alarming levels in recent years, with a significant impact on people’s quality of life and healthcare systems worldwide. Traditional weight management strategies often fall short, and many individuals struggle to maintain a healthy diet and lifestyle.
Elira recognized the need for a more personalized and effective solution to curb appetite and encourage mindful eating. This system harnesses the power of neurostimulation to create real-time interventions based on an individual’s degree of hunger and appetite.
Elira’s solution revolves around a multifaceted computer program product designed to empower users in their quest for improved dietary habits. The wearable patch provides a safe, drug-free, and non-invasive management solution.
Elira kicks off the process by prompting users to input data related to their hunger or appetite. This data can be conveniently entered via a microphone or display on their mobile device. The program then processes this input, analyzing it to establish an appetite or hunger pattern unique to each user. This step provides valuable insights into an individual’s eating habits and helps predict future appetite events.
Elira takes it a step further by determining the timing of future appetite or hunger events based on the identified patterns. This predictive capability is a game-changer, allowing users to prepare and make informed choices.
Finally, Elira generates tailored interventions based on the predicted timing of appetite or hunger events. These interventions can take various forms, such as visual displays, auditory feedback, or even recommendations for specific actions.
What sets Elira apart is its commitment to personalization. Unlike one-size-fits-all approaches, Elira adapts to each user’s unique needs and behaviors. Whether it’s recommending a specific meal, suggesting physical exercises, promoting mindfulness activities, or providing cognitive challenges, Elira’s interventions align with the individual’s goals and preferences.
Elira doesn’t stop at interventions. It also empowers users by allowing them to adjust parameters within predefined bounds, giving them a sense of control over their journey to better health. Additionally, it provides real-time feedback on dietary compliance and other relevant metrics, helping users stay on track.
Elira doesn’t just focus on calorie counting; it takes a holistic approach by integrating appetite, hunger, and craving levels with other vital data like exercise, caloric expenditure, and dietary compliance. This comprehensive view empowers users to make informed decisions about their well-being.
Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.
Who We Are:
Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.
Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.
